Medicine

All Articles

Prenatal exposure to scarcity influences lifetime health

.Attribute Medication, Released online: 09 September 2024 doi:10.1038/ d41591-024-00068-4Analysis of...

A worldwide metric of immune system health

.Nature Medication, Released online: 05 September 2024 doi:10.1038/ s41591-024-03210-4A research stu...

Niacin, food intake as well as cardiovascular effects

.Attributes Medicine, Published online: 05 September 2024 doi:10.1038/ s41591-024-03220-2Niacin, mea...

Opportunities and challenges for patient-reported result assessment in multimorbidity analysis and also technique

.Completing interests.S.E.H. obtains backing coming from the National Institute of Health as well as...

Hibernation scientific research harnessed to manage being overweight as well as change metabolic process

.Nature Medication, Posted online: 04 September 2024 doi:10.1038/ s41591-024-03226-wBy comprehending...

CAR- T as well as cell genetics treatments are actually too expensive

.Mother Nature Medicine, Posted online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-ca...

The WHO genomics system of help fair execution of individual genomics for global health

.The publication of the initial draft of the human genome sequence in 20011 was complied with due to...

Advancing international antibiotic investigation, growth and get access to #.\n\nMurray, C. J. L. et al. International worry of microbial antimicrobial resistance in 2019: a systematic evaluation. Lancet 399, 629\u00e2 $ \"655 (2022 ). AMR Frontrunnerses. In the direction of specific commitments and also action in the feedback to antimicrobial protection. Worldwide Leaders Team on Antimicrobial Resistance https:\/\/www.amrleaders.org\/resources\/m\/item\/glg-report (4 April 2024). Globe Health Company. WHO releases checklist of microorganisms for which new anti-biotics are urgently needed to have. World Wellness Company https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (27 February 2017). World Wellness Organization. WHO bacterial concern microorganisms listing, 2024: bacterial pathogens of public health usefulness to guide research, development and also techniques to avoid as well as manage antimicrobial resistance. Planet Health and wellness Organization https:\/\/www.who.int\/publications\/i\/item\/9789240093461 (17 May 2024). Silver, L. L. A Gestalt way to Gram-negative entrance. Bioorg. Medication. Chem. 24, 6379\u00e2 $ \"6389 (2016 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nSundqvist, M. Reversibility of antibiotic resistance. Ups. J. Medication. Sci. 119, 142\u00e2 $ \"148 (2014 ).\nGoogle Scholar\u00c2.\nPlanet Wellness Company. 2023 antibacterial representatives in clinical and also preclinical advancement: a summary and also evaluation. Planet Health and wellness Institution https:\/\/www.who.int\/publications\/i\/item\/9789240094000 (14 June 2024). O' Neill, J. et cetera. AMR Review. May 19, 2016 \u00e2 $\" Handling drug-resistant contaminations worldwide: last document as well as recommendations. Testimonial on Antimicrobial Resistance https:\/\/amr-review.org\/Publications.html (19 May 2016). Drive-AB Range. DRIVE-AB results: records as well as rundown. Drive abdominal muscle https:\/\/drive-ab.eu\/drive-ab-outputs\/drive-ab-reports\/ (2016 ). Stern, S. et al. Appearing the wall: an ask for concerted action on antibiotics r &amp d. Boston Consulting Team https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Berichte\/GUARD_Follow_Up_Report_Full_Report_final.pdf (February, 2017). Anderson, M., Panteli, D. &amp Mossialos, E. Plan Short 51: Just how can the EU assistance maintainable technology and also accessibility to efficient antibiotics? plan possibilities for existing and also new medicines. International Observatory on Health Solutions and Policies https:\/\/eurohealthobservatory.who.int\/publications\/i\/how-can-the-eu-support-sustainable-innovation-and-access-to-effective-antibiotics-policy-options-for-existing-and-new-medicines (21 June 2023). Turnidge, J. &amp Christiansen, K. Prescription antibiotic usage as well as resistance\u00e2 $\" showing the evident. Lancet 365, 548\u00e2 $ \"549 (2005 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nGlobe Health And Wellness Association. 2021 Conscious classification. That access, view, book, category of prescription antibiotics for evaluation and also tracking of utilization. Globe Health Association https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification (30 September 2021). International Facility for Ailment Deterrence as well as Command. Antimicrobial protection aim ats: how can our company reach them by 2030? ECDC https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/amr-brief-eaad-2023-update.pdf (2023 ). Globe Health Association. Lack of innovation readied to undermine antibiotic functionality and also wellness increases. Planet Health and wellness Company https:\/\/www.who.int\/news\/item\/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains (22 June 2022). Magnano San, L. R. et cetera. Exactly how antimicrobial resistance is connected to weather change: an outline of 2 linked worldwide obstacles. Int. J. Environ. Res. Hygienics twenty, 1681 (2023 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nDolecek, C., Shakoor, S., Basnyat, B., Okwor, T. &amp Sartorius, B. Drug-resistant bacterial infections: our company require urgent activity and investment that focus on the weakest web link. PLoS Biol. 20, e3001903 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nWorld Health And Wellness Association. Immunization protection. Planet Wellness Company https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage (15 July 2024). Chimhini, G., Magwenzi, M. &amp Fitzgerald, F. C. Infection protection and also management in low-resource environments: the demand for the neighborhood, the contextual and the pragmatic. Affect. Prev. Pract. 4, 100135 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nNour, S., Stokle, E., Ashiru-Oredope, D. &amp Wesangulae, E. Problems of applying antimicrobial stewardship tools in low to center profit countries (LMICs). Contaminate. Prev. Pract. 5, 100315 (2023 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nAminov, R. A brief past of the antibiotic period: lessons found out and also problems for the future. Front end. Microbiol. 1, 134 (2010 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nOutterson, K. et al. Client accessibility in 14 high-income countries to brand new antibacterials approved by the United States Fda, European Medicines Agency, Japanese Pharmaceuticals and also Medical Instruments Organization, or Wellness Canada, 2010\u00e2 $ \"2020. Clin. Corrupt. Dis. 74, 1183\u00e2 $ \"1190 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nGlobe Wellness Institution. 2021 antibacterial representatives in medical and preclinical growth: a review as well as study. Globe Wellness Association https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (27 May 2022). Prescription antibiotics: the economics have to assist the scientific research. Nature 625, 7 (2024 ). Thomas, D. &amp Wessel, C. The state of development in anti-bacterial therapeutics. Biotechnology Innovation Institution https:\/\/www.bio.org\/sites\/default\/files\/2022-02\/The-State-of-Innovation-in-Antibacterial-Therapeutics.pdf (February, 2022). Strich, J. et al. Evaluating clinician utilization of next-generation prescription antibiotics against insusceptible Gram-negative infections in USA health centers: a retrospective accomplice research. Ann. Trainee. Med. 177, 559\u00e2 $ \"572 (2024 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nThomas, D. &amp Wessel, C. The condition of development in anti-bacterial therapies. Biotechnology Development Company https:\/\/www.bio.org\/sites\/default\/files\/2022-04\/BIO-Antibacterial-Report-2022.pdf (February 2022). Renwick, M. J., Brogan, D. M. &amp Mossialos, E. A systematic assessment as well as essential analysis of incentive tactics for revelation as well as growth of novel prescription antibiotics. J. Antibiot. 69, 73\u00e2 $ \"88 (2016 ). Article\u00c2.\nCAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nHealth Emergency Situation Preparedness and Response Authorization. Research and development of clinical countermeasures. European Commission https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera\/preparedness\/research-and-development-medical-countermeasures_en (2024 ). International Payment. Pre-draft proposition for an International partnership under Horizon Europe One Wellness Antimicrobial Resistance. European Compensation https:\/\/research-and-innovation.ec.europa.eu\/system\/files\/2022-02\/ec_rtd_he-partnerships-onehealth-amr.pdf (9 February 2022). Worldwide Anti-biotic Research and Development Collaboration. Entasis Therapeutics and the Global Anti-biotic Study &amp Progression Collaboration to establish a brand new treatment for gonorrhea. GARDP https:\/\/gardp.org\/entasis-therapeutics-and-the-global-antibiotic-research-development-partnership-to-develop-a-new-treatment-for-gonorrhea\/ (6 July 2017). Atal, I., Trinquart, L., Porcher, R. &amp Ravaud, P. Differential globalization of field- and non-industry-sponsored professional trials. PLoS ONE 10, e0145122 (2015 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nGlobe Wellness Association. Lot of medical trial registrations through location, illness, phase of advancement, age as well as sexual activity of test attendees (1999\u00e2 $ \"2022). Planet Health and wellness Institution https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-trial-registrations-by-year-location-disease-and-phase-of-development (February 2023). International Prescription Antibiotic Trial And Error Relationship. NeoSept1: a study to establish the ranking of existing as well as new prescription antibiotics blends to treat newborn babies that reside in hospital along with severe blood poisoning. ISRCTN windows registry https:\/\/www.isrctn.com\/ISRCTN48721236 (17 January 2022). Hygienics Agency of Canada. Authorities of Canada creates important financial investment to overcome antimicrobial protection (AMR), Authorities of Canada https:\/\/www.canada.ca\/en\/public-health\/news\/2023\/05\/government-of-canada-makes-important-investment-to-fight-antimicrobial-resistance-amr.html (11 May 2023). Global Anti-biotic Research and Development Partnership. Japan federal government backing sustains GARDP\u00e2 $ s attempts to counter antibiotic resistance. GARDP https:\/\/gardp.org\/japan-government-funding-supports-gardps-efforts-to-counter-antibiotic-resistance\/ (19 October 2023). Novo Nordisk Structure. Novo Nordisk Structure partners with CARB-X to overcome drug-resistant diseases. novo nordisk foundation https:\/\/novonordiskfonden.dk\/en\/news\/novo-nordisk-foundation-partners-with-carb-x-to-fight-drug-resistant-infections\/ (9 January 2024). European Commission: European Health And Wellness and also Digital Exec Agency. Research study on delivering AMR medical countermeasures to the marketplace. Publications Office of the European Union https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/51b2c82c-c21b-11ed-8912-01aa75ed71a1\/language-en (2023 ). Outterson, K. Estimating the proper dimension of global pull incentives for anti-bacterial medications. Health Aff. 40, 1758\u00e2 $ \"1765 (2021 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nEvans, E. J., Meyer, A. &amp Conti, R. M. Dimensions a market entry perks for the development of brand new anti-biotics. Harvard Kennedy University https:\/\/www.hks.harvard.edu\/sites\/default\/files\/centers\/mrcbg\/Final_AWP_232.pdf (May 2024). Morel, C. M. et cetera. Market rewards and also antibiotic protection: an introduction to the antibiotic susceptibility benefit. J. Antibiot. 73, 421\u00e2 $ \"428 (2020 ). CAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nBonnifield, R. &amp Towse, A. An enthusiastic USG evolved devotion for subscription-based getting of unique antimicrobials and its own assumed return on investment. Center for Global Advancement https:\/\/www.cgdev.org\/publication\/ambitious-usg-advanced-commitment-subscription-based-purchasing-novel-antimicrobials (15 Nov 2022). Towse, A. &amp Silverman Bonnifield, R. G7 financial investments in brand new prescription antibiotics would certainly pay \u00e2 $\" for every person. Workplace of Wellness Economics https:\/\/www.ohe.org\/insight\/g7-investments-in-new-antibiotics-would-pay-off-for-everyone\/ (9 December 2022). NHS England. NHS improves struggle versus severe contaminations following effective world-first pilot. NHS England https:\/\/www.england.nhs.uk\/2023\/07\/nhs-steps-up-battle-against-life-threatening-infections-following-successful-world-first-pilot\/ (11 July 2023). US Our lawmakers. S. 1355 \u00e2 $\" PASTEUR Act of 2023. congress.gov www.congress.gov\/bill\/118th-congress\/senate-bill\/1355#:~:text=This%20bill%20authorizes%20the%20Department,and%20contains%20other%20related%20provisions (27 April 2023). International Commission. Reform of the EU pharmaceutical legalisation. International Payment https:\/\/health.ec.europa.eu\/medicinal-products\/pharmaceutical-strategy-europe\/reform-eu-pharmaceutical-legislation_en (26 April 2023). Gotham, D. et al. Reimbursement styles to tackle market breakdowns for antimicrobials: techniques enjoyed France, Germany, Sweden, the United Kingdom, and the United States. Wellness Policy 125, 296\u00e2 $ \"306 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nInternational Federation of Pharmaceutical Manufacturers and also Affiliations. Coming from resistance to resilience: what could the potential antibiotic pipe appear like? IFMPA https:\/\/www.ifpma.org\/publications\/from-resistance-to-resilience-what-could-the-future-antibiotic-pipeline-look-like\/ (14 May 2024). International AMR R&ampD Center &amp World Health And Wellness Company. Incentivising the development of new anti-bacterial treatments: 2023 report card by the International AMR R&ampD Hub and also That. Worldwide AMR R&ampD Center https:\/\/globalamrhub.org\/publications\/incentivising-the-development-of-new-antibacterial-treatments-2023\/ (2023 ). Glover, R. E., Performer, A., Roberts, A. P. &amp Kirchhelle, C. Why is the UK subscription version for prescription antibiotics taken into consideration successful? Lancet Micro organism 4, e852\u00e2 $ \"e853 (2023 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNon-paper \u00e2 $\" unfamiliar stimulations for the progression as well as continuing the market place of antimicrobials. Politico https:\/\/www.politico.eu\/wp-content\/uploads\/2022\/12\/01\/Non-paper-Transferable-exclusivity-voucher-for-AMR-2.pdf (2022 ). Liu, L. et cetera. Global, local, and national sources of child death in 2000\u00e2 $ \"thirteen, with projections to inform post-2015 priorities: an improved organized study. Lancet 385, 430\u00e2 $ \"440 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nQuadri, F. et cetera. Antibacterial drug deficiencies from 2001 to 2013: ramifications for professional application. Clin. Corrupt. Dis. 60, 1737\u00e2 $ \"1742 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nBenhabib, A. et al. The French coverage device for medication lacks: description and patterns coming from 2012 to 2018: an empirical retrospective study. BMJ Open 10, e034033 (2020 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nKlein, E. Y. et al. Evaluation of WHO antibiotic consumption as well as get access to targets in 76 nations, 2000\u00e2 $ \"15: a study of pharmaceutical purchases records. Lancet Infect. Dis. 21, 107\u00e2 $ \"115 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPyzik, O. Z. &amp Abubakar, I. Dealing with the counterfeits: handling ineffective as well as falsified medications. Nat. Rev. Dis. Guides 8, 55 (2022 ). Hayhoe, B., Greenfield, G. &amp Majeed, A. Is it receiving simpler to acquire prescription antibiotics in the UK? Br. J. Gen. Pract. 69, 54\u00e2 $ \"55 (2019 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nBlack Society for Research Laboratory Medication. Plan brief and also infographics on antimicrobial protection (AMR) in Africa. ASLM https:\/\/aslm.org\/resource\/policy-brief-and-infographics-on-antimicrobial-resistance-amr-in-africa\/ (14 September 2022). Kanu, J. S. et al. National antibiotic usage for individual usage in Sierra Leone (2017\u00e2 $ \"2019): a cross-sectional study. Trop. Med. Affect. Dis. 6, 77 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nNamugambe, J. S. et al. National antimicrobial intake: analysis of central stockrooms supplies to in-patient care health facilities from 2017 to 2019 in Uganda. Trop. Medication. Contaminate. Dis. 6, 83 (2021 ).\nGoogle.com Scholar\u00c2.\nRobertson, J. et al. Variations in the usage of antimicrobial medications in the European region, 2014\u00e2 $ \"2018: seekings and also ramifications coming from ESAC-Net as well as That Europe. Face. Pharmacol. 12, 639207 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nShukar, S. et cetera. Medicine shortage: causes, impact, and also relief techniques. Front. Pharmacol. 12, 693426 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K., Orubu, E. S. F., Rex, J., \u00c3 ... rdal, C. &amp Zaman, M. H. Person gain access to in 14 high-income countries to brand-new antibacterials approved by the US Food and Drug Administration, European Medicines Company, Japanese Pharmaceuticals as well as Medical Devices Company, or even Health And Wellness Canada, 2010\u00e2 $ \"2020. Clin. Affect. Dis. 74, 1183\u00e2 $ \"1190 (2021 ). Article\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nPulcini, C. et al. Lost prescription antibiotics: a follow-up inventory study in Europe, the U.S.A., Canada and Australia. Int. J. Antimicrob. Brokers 49, 98\u00e2 $ \"101 (2017 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nRottingen, J. A. &amp Farrar, J. Targeted health advancement for worldwide health and wellness. Br. Med. J. 366, 15601 (2019 ).\nGoogle Scholar\u00c2.\nAMR Sector Partnership. The 2023 AMR Market Partnership progression study: manufacturing as well as the setting. amr Field Alliance https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/12\/AMRIA_Manufacturing-and-the-environment-FINAL.pdf (2023 ). Munoz, V., Visentin, F., Foray, D. &amp Gaule, P. Can health care items be created on a non-profit basis? Exploring product progression collaborations for forgotten conditions. Sci. Public Policy 42, 315\u00e2 $ \"338 (2015 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nSwaminathan, S. et al. Restart biomedical R&ampD in the international public rate of interest. Nature 602, 207\u00e2 $ \"210 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nAfrica Centres for Illness Control as well as Avoidance. Africa CDC initiates vibrant move to get Africa\u00e2 $ s health and wellness future by generating a fifty billion dollar medical market. AfricaCDC https:\/\/africacdc.org\/news-item\/africa-cdc-spearheads-bold-move-to-secure-africas-health-future-by-creating-a-50-billion-dollar-medical-market\/ (19 February 2024). Gore, C., Morin, S., R\u00c3 \u00b8 ttingen, J. A. &amp Kieny, M. P. Bargaining public-health copyright licensing deals to increase access to health and wellness modern technologies: an insider\u00e2 $ s account. BMJ Glob. Health and wellness 8, e012964 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nSuleman, F., Low, M., Moon, S. &amp Morgan, S. G. New company styles for research and development along with cost requirements are actually needed to have to achieve decent rates of medications. Br. Med. J. 368, l4408 (2020 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nCombating Antibiotic-Resistant Microorganisms Biopharmaceutical Accelerator. Conservation and also accessibility. CARB-X https:\/\/carb-x.org\/about\/stewardship-and-access\/ (2024 ). Worldwide Anti-biotic Experimentation Alliance. Shinogi, GARDP and also CHAI announce landmark license and also collaboration agreements to deal with microbial contaminations by extending accessibility to cefiderocol in 135 countries. GARDP https:\/\/gardp.org\/shionogi-gardp-and-chai-announce-landmark-license-and-collaboration-agreements-to-treat-bacterial-infections-by-expanding-access-to-cefiderocol-in-135-countries\/ (15 June 2022). AMR Field Partnership. Leaving behind the laboratory: tracking the downtrend in AMR R&ampD specialists. amr Field Collaboration https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/02\/Leaving-the-Lab_final-1.pdf (February, 2024). G7 Health Ministers. G7 Health And Wellness Ministers\u00e2 $ Communiqu\u00c3 \u00a9. G7 Germany www.g7germany.de\/resource\/blob\/974430\/2042058\/5651daa321517b089cdccfaffd1e37a1\/2022-05-20-g7-health-ministers-communique-data.pdf (20 May 2022). G20. G20 call to action on antimicrobial protection. G7G20 Records Data source https:\/\/g7g20-documents.org\/database\/document\/2022-g20-indonesia-sherpa-track-health-ministers-ministers-annex-g20-call-to-action-on-antimicrobial-resistance (28 Oct 2022). International Union on Getting Older &amp Transmittable Illness Society of The United States. 2024 AMR readiness mark report card. Gauging authorities action on AMR plan. Global Union on Aging https:\/\/globalcoalitiononaging.com\/wp-content\/uploads\/2024\/01\/2024-AMR-Index-Progress-Report.pdf (2024 ). Food Items and also Horticulture Company of the United Nations, United Nations Setting Program, Planet Wellness Association &amp. Globe Company for Pet Health And Wellness. Global database for tracking antimicrobial protection (AMR): nation self-assessment study (TrACSS). WHO https:\/\/amrcountryprogress.org\/

/map-viewindicator2.3 (2023 ). Vehicle Katwyk, S. R. &amp Outterson K. Introduction: AMR belongs in ...

Integrating liver endpoints in scientific tests of cardiovascular and also kidney health condition

.Attribute Medicine, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of v...